Application of kidney-nourishing and fetus-cultivating pill in preparing medicine for preventing preeclampsia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A preeclampsia, drug technology, applied in the field of medicine
Active Publication Date: 2020-04-07
GUANGZHOU BAIYUNSHAN ZHONGYI PHARMA COMPANY
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, Zishen Yutai pills have not been reporte
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] Example 1 Effect of Zishen Yutai Pills on the condition of high-risk pregnant women with preeclampsia
[0022] (1) Purpose of the experiment
[0023] Through comparison, analyze and evaluate the clinical curative effect of the present invention on condition control of pregnant women with high risk of preeclampsia.
[0024] (2) Experimental methods and results
[0025] Select 160 pregnant women who met the high-risk standard of preeclampsia in 2016-2017, and randomly divide them into the Zishen Yutai Pill group and the placebo group according to the order of treatment, and use the present invention as a control observation between the two groups after treatment.
[0026] Source of patients: All cases were from outpatients of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine.
[0027] Inclusion criteria:
[0028] 1. 12-20 weeks of pregnancy, single pregnancy;
[0029] 2. Contain at least one of the following conditions: pre-pregnanc...
Embodiment 2
[0044] Example 2 Effect of Zishen Yutai Pills on Pregnancy Outcome of Preeclampsia High Risk Pregnant Women
[0045] (1) Purpose of the experiment
[0046] Through comparison, analyze and evaluate the clinical curative effect of the present invention on the pregnancy outcome of pregnant women with high risk of preeclampsia.
[0047] (2) Experimental methods and results
[0048] Select 130 pregnant women who meet the high-risk standard of preeclampsia in 2016-2017, and randomly divide them into the Zishen Yutai Pill group and the placebo group according to the order of treatment, and use the present invention as a control observation between the two groups after treatment.
[0049] Source of patients: All cases were from outpatients of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine.
[0050] Inclusion criteria:
[0051] 1. 12-20 weeks of pregnancy, single pregnancy;
[0052] 2. Contain at least one of the following conditions: pre-preg...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention provides an application of a kidney-nourishing and fetus-cultivating pill in preparing a medicine for preventing preeclampsia. The kidney-nourishing and fetus-cultivating pill has a relatively good effect on preventing the preeclampsia, can obviously reduce preeclampsia morbidity of high-risk pregnant women in the preeclampsia, can inhibit progress of the disease into early-onset type preeclampsia, severe preeclampsia and gestational hypertension, improves maternal and infant outcome, reduces postpartum hemorrhage incidence, premature birth rate and neonatal NICU survivalrate, and increases neonatal body weight normality rate. The result shows that the kidney-nourishing and fetus-cultivating pill can improve pregnancy outcome of the pregnant women with high risk of the preeclampsia by preventing occurrence of the preeclampsia.
Description
technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of Zishen Yutai Pills in the preparation of medicines for preventing preeclampsia. Background technique [0002] Preeclampsia is a kind of hypertensive disorder in pregnancy (PIH). It is a disease unique to women during pregnancy. Its clinical manifestations are mainly high blood pressure and proteinuria after 20 weeks of pregnancy in women with normal blood pressure before pregnancy. The incidence of preeclampsia is high, about 3-5%; the condition changes rapidly, and it is prone to serious complications such as HELLP syndrome, placental abruption, eclampsia, premature delivery, and fetal distress. one of the diseases. [0003] Although the incidence of preeclampsia is high and the condition is critical, the pathogenesis is still unclear. At present, the following 6 points are recognized: 1. abnormal trophoblast cells invade the myometrium; 2. vascular endot...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more